127 related articles for article (PubMed ID: 196437)
1. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
Vogelberg KH; Althoff B; Heggen EM; Thesseling W
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():832-5. PubMed ID: 196437
[No Abstract] [Full Text] [Related]
2. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
Vogelberg KH
Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Gaertner U; Johannes KJ
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of hyperlipemia and hyperuricemia with a combination of clofibrate and an extractive mucopolysaccharide complex].
Loizzi P; Terlizzi N
Reumatismo; 1975; 27(1):157-62. PubMed ID: 184507
[No Abstract] [Full Text] [Related]
6. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
[TBL] [Abstract][Full Text] [Related]
7. Familial lipoatrophic diabetes with dominant transmission. A new syndrome.
Dunnigan MG; Cochrane MA; Kelly A; Scott JW
Q J Med; 1974 Jan; 43(169):33-48. PubMed ID: 4362786
[No Abstract] [Full Text] [Related]
8. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
Schwartzkopff W; Hoffmann H; Kästner W
Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
[No Abstract] [Full Text] [Related]
9. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
10. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
11. Gemfibrozil treatment: a comparison with clofibrate.
Howard AN; Ghosh P
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
[TBL] [Abstract][Full Text] [Related]
12. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
Weisweiler P; Schwandt P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
[No Abstract] [Full Text] [Related]
13. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
Miettinen TA; Penttilä IM; Lampainen E
Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
[No Abstract] [Full Text] [Related]
14. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
Jantke J; Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057
[No Abstract] [Full Text] [Related]
15. Diet and drug treatment of hyperlipidemia and atherosclerosis.
Kuo PT
Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
[No Abstract] [Full Text] [Related]
16. Secholex, Clofibrate and taurine in hyperlipidaemia.
Howard AN; Evans RJ
Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405
[No Abstract] [Full Text] [Related]
17. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
18. [The when and how of therapy for hyperlipoproteinemia].
Mordasini R
Schweiz Med Wochenschr; 1978 Jan; 108(4):113-9. PubMed ID: 203028
[TBL] [Abstract][Full Text] [Related]
19. [Current trends in the therapy of arteriosclerotic disease].
Toscano S
G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
[No Abstract] [Full Text] [Related]
20. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]